رفرنس استاندارد لیدوکائین هیدروکلراید Lidocaine Hydrochloride (150 mg) 1366013 USP
رفرنس استاندارد لیدوکائین هیدروکلراید Lidocaine Hydrochloride (150 mg) 1366013 USP
رفرنس استاندارد لیدوکائین هیدروکلراید Lidocaine Hydrochloride (150 mg) 1366013 USP
لینک کالا در سایت سیگما ( کلیک کنید )
لینک کالا در سایت USP ( کلیک کنید )
برگه انالیز کالا ( کلیک کنید )
THIS ITEM HAS BEEN IDENTIFIED AS A POTENTIALLY DANGEROUS GOOD. SPECIAL SHIPPING METHODS AND CHARGES MAY APPLY.
Lidocaine Hydrochloride (150 mg)
Catalog No:
1366013
CAS RN®
6108-05-0
Molecular Formula:
C14H22N2O.HCl.H2O
Product Type:
Reference Standard
Related Products
remove quantity box add
Add to Cart
star Add to Favorites
Current Lot Information
Current Lot: R10460
CAS RN® 6108-05-0
Harmonized System (HS) Code *: 292429
UN No: UN2811
NDC No: N/A
Molecular Formula: C14H22N2O.HCl.H2O
Container Type: VIAL
Base Control Substance (substance %): N/A
1366013
USP
Copy Link
Lidocaine hydrochloride
No rating value Same page link.
(0)
Write a review
Ask a question
United States Pharmacopeia (USP) Reference Standard
Sign Into View Organizational & Contract Pricing
Select a Size
Change View
150 MG
€392.00
Synonym(s):
Lidocaine hydrochloride monohydrate, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide hydrochloride monohydrate, Lignocaine hydrochloride monohydrate, Xylocaine hydrochloride monohydrate
Empirical Formula (Hill Notation):
C14H22N2O · HCl · H2O
CAS Number:
Molecular Weight:
288.81
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24
Properties
grade
pharmaceutical primary standard
API family
lidocaine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
Cl[H].[H]O[H].CCN(CC)CC(=O)Nc1c(C)cccc1C
InChI
1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2
InChI key
YECIFGHRMFEPJK-UHFFFAOYSA-N
Gene Information
human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)
Description
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
This USP reference standard is intended for use in specified quality tests and assays.
Also used to prepare the standard solution for the assay and impurity analysis as described in the United States Pharmacopeia (USP) monograph.
Biochem/physiol Actions
Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
